107 related articles for article (PubMed ID: 9000651)
1. Lysophosphatidylcholine induces Ca2+-independent cellular injury attenuated by d-propranolol in rat cardiomyocytes.
Chen M; Hashizume H; Xiao CY; Hara A; Abiko Y
Life Sci; 1997; 60(3):PL57-62. PubMed ID: 9000651
[TBL] [Abstract][Full Text] [Related]
2. Effects of beta-adrenoceptor antagonists on Ca(2+)-overload induced by lysophosphatidylcholine in rat isolated cardiomyocytes.
Chen M; Hashizume H; Abiko Y
Br J Pharmacol; 1996 Jun; 118(4):865-70. PubMed ID: 8799555
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of quinaprilat, an active metabolite of quinapril, on Ca2+-overload induced by lysophosphatidylcholine in isolated rat cardiomyocytes.
Ma H; Hashizume H; Hara A; Yazawa K; Abiko Y
Jpn J Pharmacol; 1999 Jan; 79(1):17-24. PubMed ID: 10082313
[TBL] [Abstract][Full Text] [Related]
4. Phospholipase A2 is not responsible for lysophosphatidylcholine-induced damage in cardiomyocytes.
Chen M; Xiao CY; Hashizume H; Abiko Y
Am J Physiol; 1998 Nov; 275(5):H1782-7. PubMed ID: 9815086
[TBL] [Abstract][Full Text] [Related]
5. Extracellulary administered lysophosphatidylcholine causes Ca2+ efflux from freshly isolated adult rat cardiomyocytes.
Itoh K; Yoshizumi M; Kitagawa T; Fukuta Y; Hori T; Houchi H; Tamaki T; Katoh I
Basic Res Cardiol; 1998 Feb; 93(1):23-9. PubMed ID: 9538934
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of Ca2+ channel blockers on Ca2+ overload induced by lysophosphatidylcholine in cardiomyocytes.
Chen M; Xiao CY; Hashizume H; Abiko Y
Eur J Pharmacol; 1997 Aug; 333(2-3):261-8. PubMed ID: 9314043
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of lysophosphatidylcholine-induced increase in intracellular calcium in rat cardiomyocytes.
Yu L; Netticadan T; Xu YJ; Panagia V; Dhalla NS
J Pharmacol Exp Ther; 1998 Jul; 286(1):1-8. PubMed ID: 9655835
[TBL] [Abstract][Full Text] [Related]
8. How does beta-adrenergic stimulation increase the heart rate? The role of intracellular Ca2+ release in amphibian pacemaker cells.
Ju YK; Allen DG
J Physiol; 1999 May; 516 ( Pt 3)(Pt 3):793-804. PubMed ID: 10200426
[TBL] [Abstract][Full Text] [Related]
9. A study on dilazep: II. Dilazep attenuates lysophosphatidylcholine-induced mechanical and metabolic derangements in the isolated, working rat heart.
Hoque AN; Hoque N; Hashizume H; Abiko Y
Jpn J Pharmacol; 1995 Mar; 67(3):233-41. PubMed ID: 7630041
[TBL] [Abstract][Full Text] [Related]
10. [Cardiac cell injury induced by lysophosphatidylcholine].
Hashizume H; Abiko Y
Nihon Yakurigaku Zasshi; 1999 Nov; 114(5):287-93. PubMed ID: 10621942
[TBL] [Abstract][Full Text] [Related]
11. Ryanodine releases calcium from sarcoplasmic reticulum in calcium-tolerant rat cardiac myocytes.
Hansford RG; Lakatta EG
J Physiol; 1987 Sep; 390():453-67. PubMed ID: 3127576
[TBL] [Abstract][Full Text] [Related]
12. A new approach to the development of anti-ischemic drugs: protective drugs against cell injury induced by lysophosphatidylcholine.
Hashizume H; Chen M; Ma H; Hara A; Yazawa K; Akahira M; Xiao CY; Abiko Y
Life Sci; 1998; 62(17-18):1695-9. PubMed ID: 9585159
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidyl choline potentiates Ca2+ accumulation in rat cardiac myocytes.
Sedlis SP; Corr PB; Sobel BE; Ahumada GG
Am J Physiol; 1983 Jan; 244(1):H32-8. PubMed ID: 6849404
[TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidylcholine increases cytosolic calcium in ventricular myocytes by direct action on the sarcolemma.
Woodley SL; Ikenouchi H; Barry WH
J Mol Cell Cardiol; 1991 Jun; 23(6):671-80. PubMed ID: 1658342
[TBL] [Abstract][Full Text] [Related]
15. Cobra venom cardiotoxin induces perturbations of cytosolic calcium homeostasis and hypercontracture in adult rat ventricular myocytes.
Wang HX; Lau SY; Huang SJ; Kwan CY; Wong TM
J Mol Cell Cardiol; 1997 Oct; 29(10):2759-70. PubMed ID: 9344770
[TBL] [Abstract][Full Text] [Related]
16. Propranolol prevents the development of heart failure by restoring FKBP12.6-mediated stabilization of ryanodine receptor.
Doi M; Yano M; Kobayashi S; Kohno M; Tokuhisa T; Okuda S; Suetsugu M; Hisamatsu Y; Ohkusa T; Kohno M; Matsuzaki M
Circulation; 2002 Mar; 105(11):1374-9. PubMed ID: 11901051
[TBL] [Abstract][Full Text] [Related]
17. A new approach to the development of anti-ischemic drugs. Substances that counteract the deleterious effect of lysophosphatidylcholine on the heart.
Hashizume H; Hoque AN; Magishi K; Hara A; Abiko Y
Jpn Heart J; 1997 Jan; 38(1):11-25. PubMed ID: 9186278
[TBL] [Abstract][Full Text] [Related]
18. The effect of isoflurane during reoxygenation on the sarcoplasmic reticulum and cellular injury in isolated ventricular myocytes.
Dworschak M; Breukelmann D; Hannon JD
Life Sci; 2006 Jan; 78(8):888-93. PubMed ID: 16137699
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of quinaprilat and trandolaprilat, active metabolites of quinapril and trandolapril, on hemolysis induced by lysophosphatidylcholine in human erythrocytes.
Hayase N; Satomi M; Hara A; Awaya T; Shimizu K; Matsubara K
Biol Pharm Bull; 2003 May; 26(5):712-6. PubMed ID: 12736518
[TBL] [Abstract][Full Text] [Related]
20. Beta-adrenoceptor antagonists and the release of creatine phosphokinase from hypoxic heart muscle.
Nayler WG; Grau A; Yepez C
Cardiovasc Res; 1977 Jul; 11(4):344-52. PubMed ID: 19152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
